Year 2015 (49)

Edition nr. 8


www.xtluis.nl

The information on the XTLuis® website is not incorrect, and dimeticon is not a bad choice to treat head lice. The website emphasises the combination therapy (anti-lice agent plus combing), which is not surprising as such a site is of course inte ...

Read article


Ten myths about the pharmaceutical industry: myth 7

7. Drug research is intended to improve patient treatment The general comments made by Danish physician Peter Gøtzsche in his book ‘Deadly medicines and organised crime’ have obviously been worked out in more detail in his book, but they are also ...

Read article


NHG Guideline on Acute Otitis Media in Children

The recommendation to be reticent in prescribing antibiotics for acute otitis media is justified, as this disorder is usually self-limiting. The risk of complications is also low: the risk of acute mastoiditis among children below 15 years of age ...

Read article


NHG Guideline on Deep Vein Thrombosis and Pulmonary Embolism

The Guideline on Deep Vein Thrombosis (DVT) and Pulmonary Embolism published by the Dutch College of General Practitioners (NHG) does not recommend the use of DOACs. This is sensible advice, in view of the existing uncertainty about their safety ...

Read article


Treatment strategy for pneumonia immediately after hospital admission

The study discussed here, which involved large numbers of patients, was not sponsored by the pharmaceutical industry, and addressed a problem that is relevant to medical practice, is a remarkable exception among the huge range of industry-sponsor ...

Read article


Publication bias investigated by ex-employee of pharmaceutical company

The term publication bias means that the studies published in medical journals do not fully reflect all the research studies that are actually undertaken. The suggestion is that especially studies with a negative outcome are not being published. ...

Read article


Ezetimibe added to simvastatin after acute coronary syndrome: very limited result after various study adjustments

Over ten years after ezetimibe was authorised for the treatment of hyperlipidaemia, in combination with a statin, a study sponsored by the manufacturer has found that this combination offers greater reduction of the serum LDL concentration in pat ...

Read article


Umeclidinium, Incruse® Ellipta® (GSK)

Dry Powder Inhaler 55 µg Maintenance treatment of COPD The manufacturer has asked for umeclidinium inhaler powder to be included in the cluster of long-acting bronchodilators, which also includes the three other long-acting muscarinic receptor an ...

Read article